SS
EDIT icon

SBI Securities’s Editas Medicine EDIT Stock Holding History

SBI Securities’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Buy
3,316
+375
+13% +$1.1K ﹤0.01% 1794
2026
Q1 		$7.26K Sell
2,941
-2,418
-45% -$5.12K ﹤0.01% 1870
2025
Q4 		$11K Buy
5,359
+2,318
+76% +$6.69K ﹤0.01% 1687
2025
Q3 		$10.6K Sell
3,041
-407
-12% -$1.14K ﹤0.01% 1749
2025
Q2 		$7.59K Buy
3,448
+486
+16% +$795 ﹤0.01% 1817
2025
Q1 		$3.44K Buy
2,962
+146
+5% +$215 ﹤0.01% 2056
2024
Q4 		$3.58K Buy
+2,816
New +$7.17K ﹤0.01% 2053

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SBI Securities's EDIT Position: Q2 2026 in Review

SBI Securities increased its Editas Medicine (EDIT) stake by 13% in Q2 2026, buying an estimated $1.1K and bringing the position to 3,316 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1794.

SBI Securities first reported a position in EDIT in Q4 2024 and has held it in 7 quarters since. The position peaked at $11K in Q4 2025. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • SBI Securities held 3,316 shares of Editas Medicine worth $10.7K as of Q2 2026.
  • SBI Securities bought 375 Editas Medicine shares in Q2 2026, an estimated $1.1K.
  • Editas Medicine made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1794 holding.
  • SBI Securities first reported a position in Editas Medicine in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Editas Medicine position peaked at $11K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.